Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00805545 · ClinicalTrials.gov registry record · NA

Timing of Antibiotic Prophylaxis for Cesarean Deliveries

A NA study of Infection, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT00805545 is a NA study of Infection that has completed, run by University of Florida. The registered enrollment target is 400 participants, below the 717-participant average among 41 other Infection trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00805545, a NA study of Infection, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

The current standard of care to prevent post partum infectious morbidities is to administer antibiotic prophylaxis to all women undergoing a cesarean delivery. The general practice is to administer the antibiotic immediately after the umbilical cord is clamped. This study will compare the incidence of post partum infectious morbidities when the extended spectrum prophylaxis given before the incision time vs. the time of cord clamp.

Conditions Studied

Interventions

  • DRUG Antibiotic

Study Locations (1)

Florida

  • Shands Hospital - Gainesville

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2008-11
Est. Completion 2009-11
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT00805545

The ClinicalTrials.gov registry entry for NCT00805545 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 400 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 717-participant average among 41 other Infection trials with a reported enrollment target (44% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infection appearing as the primary indexed condition, and to 1 intervention - of which Antibiotic is the first listed.

NCT00805545 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT00805545 about?

NCT00805545 is a clinical study titled "Timing of Antibiotic Prophylaxis for Cesarean Deliveries". The current standard of care to prevent post partum infectious morbidities is to administer antibiotic prophylaxis to all women undergoing a cesarean delivery. The general practice is to administer the antibiotic immediately after the umbilical cord is clamped. This study will compare the incidence ...

What is the current status of trial NCT00805545?

This trial is currently completed. It is a NA study. The enrollment target is 400 participants. The study started on 2008-11. Estimated completion is 2009-11.

What conditions does trial NCT00805545 study?

This clinical trial studies the following conditions: Infection.

What interventions are being tested in trial NCT00805545?

The interventions under investigation include: Antibiotic (DRUG).

Who is sponsoring clinical trial NCT00805545?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00805545 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infection

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.